Skip to main content
. 2017 Apr 7;31(3):650–660. doi: 10.1111/jvim.14655

Figure 2.

Figure 2

Plasma N‐terminal probrain natriuretic peptide (NT‐proBNP) concentrations in healthy cats, (n = 25), cats with chronic kidney disease (n = 25), hypertensive cats without evidence of hypertensive ocular target organ damage (HT‐noTOD) (n = 24), and hypertensive cats with evidence of hypertensive retinopathy (HT‐ocular‐TOD) (n = 25). HT‐TOD had significantly higher plasma NT‐proBNP concentration than healthy cats (P < .001).